Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: 0.12 (1.45%)
Spread: 0.20 (2.439%)
Open: 8.30
High: 8.42
Low: 8.30
Prev. Close: 8.30
ANIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Circular and Notice of General Meeting

29 Mar 2019 07:00

RNS Number : 3967U
Port Erin Biopharma Investments Ltd
29 March 2019
 

7.00am 29 March 2019

 

Port Erin Biopharma Investments Limited

(the "Company")

 

Circular and Notice of General Meeting

 

The Company is pleased to announce that it has today posted a Circular to Shareholders seeking approval for a change of its Investing Policy and a name change to Agronomics Limited. The General Meeting ("GM") will be held at the Claremont Hotel, Loch Promenade, Douglas, Isle of Man IM1 2LX, at 11:00 a.m. on 16 April 2019. A copy of the Circular is being posted to Shareholders and is available on the Company's website, https://www.porterinbiopharma.com.

 

The proposed new Investing Policy is as follows:

 

 

''The Company will invest in opportunities within the Life Sciences sector, concentrating on, but not being limited to, environmentally friendly alternatives to the traditional production of meat and plant-based nutrition sources ("Clean Food"). The Company will focus on investments that provide scalable and commercially viable opportunities.

The Company will invest in equity and equity related products in both quoted companies, which offer the benefits of liquidity, and in unquoted companies which offer the attraction of additional capital gains upon completion of a successful IPO. The Company may also invest in shares of collective investment schemes with exposure to the Life Science sector and in long-term equity anticipation securities the underlying securities of which will be based on Life Science sector securities and/or indices relating to the Life Science sector. The Fund may invest in Life Science Sector debt. Investments in Life Science sector debt shall not exceed 15 per cent. of the Net Asset Value of the Company.

The Company will be ungeared. The Company will be a passive investor.

The Company aims to deliver capital growth by realising capital gains when it considers that the valuation of individual investments looks to be excessive or, as is often the case in this sector, as a result of trade sales.

Assets and investments will be held by the Company directly or through the individual share custodians of the brokers used by the Company to acquire the shares.

Any material variation to the Investing Policy will require the approval of Shareholders at a general meeting of the Company in accordance with the AIM Rules for Companies.''

As an Investing Company, the Company's investing policy is subject to annual renewal by Shareholders to the extent it has not been fully implemented.

 

The expected timetable of principal events and details of the name change are as follows:

 

28 March 2019

Publication of this Document

28 March 2019

Posting to Shareholders of this Document

30 March 2019

Latest time and date for receipt of Forms of Proxy

13:00 p.m. on 12 April 2019

General Meeting

11.00 a.m. on 16 April 2019

Trading expected to commence under new name and ISIN

9:00 a.m. on 23 April 2019

New Name of Company after the General Meeting

Agronomics Limited

New TIDM following the General Meeting

ANIC

New website if change of name is approved

www.agronomics.im

 

 

For further information, please contact:

 

Port Erin Biopharma

Investments Limited

Beaumont Cornish Limited

Optiva Securities Limited

The Company

Nomad

Broker

 

 

 

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKMGZFNRKGLZM
Date   Source Headline
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:00 pmRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSPortfolio Update: Solar Foods receives EUR4.3m
19th Nov 20207:00 amRNSAnnounces Investment of US$ 5 million in BlueNalu
11th Nov 20202:59 pmRNSAgronomics November Newsletter 2020
10th Nov 20209:46 amRNSClosure of Broker Option & TVR
2nd Nov 20207:00 amRNSHolding(s) in Company
26th Oct 20207:00 amRNSEquity Fundraise of £10.0 million
15th Oct 20207:30 amRNSInvestee Company Update: LIVEKINDLY Collective
15th Oct 20207:00 amRNSNet Asset Value(s)
29th Sep 20202:54 pmRNSPortfolio Company Shiok Meats completes Financing
29th Sep 20207:00 amRNSAppointment of Joint Broker
25th Sep 20207:00 amRNSAnnounces Participation in Mosa Meat Financing
1st Sep 20201:00 pmRNSInvestment in Solar Foods EUR 15million Financing
12th Aug 20207:00 amRNSDirectorate Change
20th Jul 20207:00 amRNSNet Asset Value - 30 June 2020
1st Jul 202012:00 pmRNSConclusion of consultation being to remain on AIM
19th Jun 20207:00 amRNSConsultation on Possible De-Listing & Tender Offer
15th Jun 202012:10 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSCo-lead of Meatable B.V.’s Seed 2 Financing
14th Apr 20207:00 amRNSNet Asset Value calculation to 31 March 2020
6th Apr 20203:49 pmRNSNEWSLETTER 06/04/2020
2nd Apr 202011:59 amRNSPortfolio Company Update: GALY CO.
2nd Apr 20207:00 amRNSPortfolio Company Update: GALY CO
1st Apr 20207:00 amRNSFurther investment in Rebellyous Foods
31st Mar 202010:56 amRNSSubscription of US$2,999,996 in Tropic Biosciences
13th Mar 20207:00 amRNSPortfolio Company Update: Foods United
10th Mar 20207:00 amRNSInvestment of US$ 500,000 in GALY CO.
27th Feb 20207:00 amRNSPortfolio Company BlueNalu Announces Financing
13th Feb 20207:00 amRNSAdditional Investment of US$1 Million in VitroLabs
12th Feb 20207:00 amRNSInvestment of US$3million in Foods United
4th Feb 20201:04 pmRNSResult of AGM
31st Jan 20204:42 pmRNSHolding(s) in Company
28th Jan 20203:58 pmRNSHolding(s) in Company
24th Jan 20201:00 pmRNSFurther Equity Fundraise of £5.5 million
16th Jan 20202:05 pmRNSSecond Price Monitoring Extn
16th Jan 20202:00 pmRNSPrice Monitoring Extension
16th Jan 20207:00 amRNSHalf-year Report
27th Dec 201912:30 pmRNSIssue of Equity
20th Dec 20197:00 amRNSInvestment in Meatable BV
19th Dec 20197:00 amRNSAdditional Participation in BlueNalu Fundraise
18th Dec 20197:00 amRNSInvestment in LegenDairy Foods GmbH
16th Dec 20194:02 pmRNSHolding(s) in Company
16th Dec 20193:33 pmRNSHolding(s) in Company
12th Dec 20196:01 pmRNSHolding(s) in Company
11th Dec 201912:00 pmRNSInvestment in Oritain Global Limited
9th Dec 20193:00 pmRNSEquity Fundraise Closes at £7.7 million
6th Dec 20197:00 amRNSFinal Results
4th Dec 20197:00 amRNSUpdate on Placing and Final Results
11th Nov 20197:00 amRNSProposed Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.